Pilot and Feasibility Program in Human Islet Biology
The summary for the Pilot and Feasibility Program in Human Islet Biology grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Pilot and Feasibility Program in Human Islet Biology: Much of our understanding of the basic biology and function of the beta cell and the pancreatic islet comes from studies of immortalized cell lines and mouse tissue. However, differences in the general structure and organization of mouse and human islets have been identified, and it remains uncertain if these structural differences reflect functional differences as well. With the variable success in islet transplantation and the inability to use in vitro data to reliably predict islet engraftment and function, it is important to learn all that we can about the structure, organization, and signaling properties of human islets, and to compare and contrast these findings with those reported with rodent models of islet function used to date. The information gained from these studies should increase our ability to develop new reagents for use in in vivo imaging studies of the human islet, to develop fingerprinting assays for use in predicting human islet transplant success, and to further develop cellular therapies for potential use in the treatment of type 1 diabetes.
|Federal Grant Title:||Pilot and Feasibility Program in Human Islet Biology|
|Federal Agency Name:||National Institutes of Health|
|Type of Opportunity:||Discretionary|
|Funding Opportunity Number:||RFA-DK-03-021|
|Type of Funding:||Grant|
|CFDA Descriptions:||Diabetes, Endocrinology and Metabolism Research|
|Current Application Deadline:||No deadline provided|
|Original Application Deadline:||November 20, 2003 and July 20, 2004|
|Posted Date:||Jul 22, 2003|
|Creation Date:||Aug 19, 2004|
|Archive Date:||Aug 19, 2004|
|Total Program Funding:|
|Maximum Federal Grant Award:|
|Minimum Federal Grant Award:|
|Expected Number of Awards:|
|Cost Sharing or Matching:||No|
- Applicants Eligible for this Grant
- State governments County governments City or township governments Special district governments Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses Small businesses Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster FBOWebmaster@OD.NIH.GOV NIH OER Webmaster
- Similar Government Grants
- • Limited Competition for the Continuation of the Hepatitis B Research Network Clinical Cent...
- • Kidney Precision Medicine Project Recruitment Sites (UG3/UH3)
- • NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC) Genetic Research Centers (GRC...
- • Kidney Precision Medicine Project Central Hub (U2C)
- • Limited Competition for Data Coordinating Center (DCC) for NIDDK Inflammatory Bowel Diseas...
- • Proteomic and Metabolomic Approaches to Diagnose Diabetes and Pre-Diabetes
- • Molecular Therapy Core Centers
- • Diabetes Endocrinology Research Centers
- More Grants from the National Institutes of Health
- • Learning Disabilities Research Centers (P50)
- • NIAMS Clinical Trial Planning Grant (R34)
- • NIAMS Clinical Trial Implementation Cooperative Agreement (U01)
- • Short-term Measurements of Physical Resilience as a Predictor of Healthspan in Mice (R01)
- • Basic and Translational Research on Decision Making in Aging and Alzheimer's Disease (R01)